Carregant...
Rituximab (Rituxan)
Rituximab is a monoclonal antibody that was first approved by the FDA as an antineoplastic agent designed to treat B-cell malignancies. This article will review the mechanism of action and clinical role of this anti-B-cell agent.
Guardat en:
| Publicat a: | AJNR Am J Neuroradiol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Neuroradiology
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7965451/ https://ncbi.nlm.nih.gov/pubmed/20448016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A2142 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|